Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation

Next Previous
Search
Trial Profile

Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edoxaban (Primary) ; Fluindione; Phenindione; Phenprocoumon; Vitamin K antagonists; Warfarin
  • Indications Embolism and thrombosis; Myocardial infarction; Stroke
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms ENVISAGE-TAVI AF
  • Sponsors Daiichi Sankyo Company; Daiichi Sankyo Inc

    • Most Recent Events

    • 01 Mar 2025 Results analyzing annualized clinical event rates in patients with and without a recent PCI published in the Clinical Research in Cardiology.
    • 13 Nov 2023 Results of post hoc sub-analysis assessing whether efficacy and safety of EDO vs VKA in patients with AF undergoing TAVR will vary across the range of baseline CrCl, presented at the American Heart Association Scientific Sessions 2023
    • 13 Nov 2023 Results analyzing association between anticoagulation treatment duration and patient-reported outcomes (PROs) and treatment satisfaction, presented at the American Heart Association Scientific Sessions 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top